ALPINE IMMUNE SCIENCES INC (ALPN)

US02083G1004 - Common Stock

64.6  0 (0%)

After market: 64.6 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
58.88M30.06M23.44M9.34M1.74M
Operating Expenses
103.13M88.21M73.30M38.08M45.31M
Research and Development
80.90M70.24M58.74M27.19M35.85M
Selling, General, and Administrative Expenses
22.22M17.97M14.56M10.90M9.47M
Operating Income
-44.25M-58.15M-49.86M-28.75M-43.57M
Interest Income/Expense
11.75M2.81M-560.00K-530.00K910.00K
Other Income/Expense
415.00K-100.00K0.001.33M810.00K
Non Recurring Items
N/AN/AN/A0.000.00
Income Before Taxes
-32.08M-55.43M-50.42M-27.95M-41.85M
Income Tax
103.00K2.33M-90.00K-10.00K0.00
Net Income
-32.18M-57.76M-50.33M-27.94M-41.85M
EBITDA
-43.67M-57.55M-49.24M-28.17M-43.10M
 
Per Share Data
EPS Diluted Total Ops
-0.64-1.73-1.98-1.34-2.28
Non GAAP EPS
-0.67-1.68-1.98-1.38-2.29
 
Statistics
Profit Margin
-54.66%-192.15%-214.72%-299.14%-2405.17%
Operating Profit Margin
-75.16%-193.45%-212.71%-307.82%-2504.02%

All data in USD

Charts